在处方阿片类药物逐渐减少期间支持慢性疼痛患者的短信干预:双盲随机对照试验的协议
Ali Gholamrezaei1, Michael Reece Magee1, Amy Gray McNeilage1
1Pain Management Research Institute, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.
BMJ open
|October 25, 2023
概括
这项研究测试了一种短信干预措施,以支持慢性非癌症疼痛 (CNCP) 患者的长期阿片类药物治疗 (LTOT). 该干预旨在减少阿片类药物剂量减少期间的疼痛和改善生活质量.
科学领域:
- 疼痛管理 疼痛管理
- 数字健康干预措施 数字健康干预措施
- 在阿片类药物紧固化支持下,支持支.
背景情况:
- 慢性非癌症疼痛 (CNCP) 患者逐渐减少长期阿片类药物治疗 (LTOT) 往往会增加疼痛和降低生活质量.
- 对疼痛自我管理的社会和心理支持可能有助于在不加剧疼痛的情况下降低阿片类药物剂量.
研究的目的:
- 评估短信干预措施的有效性,为接受阿片类药物减量治疗的CNCP患者提供社会和心理支持.
- 评估干预对疼痛强度,干扰,情绪,自我效能和戒断症状的影响.
主要方法:
- 一个双盲,随机对照试验,涉及74名CNCP患者在澳大利亚各地逐渐减少LTOT.
- 参与者接受了心理教育视频与每日支持性短信 (SMS) 或视频单独12周.
- 主要结局测量疼痛强度和干扰;次要结局包括情绪,自我有效性和阿片类药物剂量减少.
主要成果:
- 该研究旨在提供有关短信干预措施的有效性和安全性的证据.
- 数据收集包括在基线和每4周进行12周的问卷调查,并进行最后的采访.
结论:
- 这项研究将确定低成本的短信干预是否可以在阿片类药物逐渐减少期间有效支持CNCP患者.
- 如果证明有效和安全,该干预措施有可能在临床实践中进行可扩展的实施.
相关概念视频
01:25Analgesia and Pain Management
636
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
636
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
311
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311